JAGSONPAL PHARMACEUTICALS
Back to Cashflow Statement
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-12 Cr | ₹-8.91 Cr | ₹-0.46 Cr | ₹-18 Cr | ₹-6.83 Cr |
What is the latest Cash Flow from Financing Activities ratio of JAGSONPAL PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-12 Cr |
| Mar2024 | ₹-8.91 Cr |
| Mar2023 | ₹-0.46 Cr |
| Mar2022 | ₹-18 Cr |
| Mar2021 | ₹-6.83 Cr |
How is Cash Flow from Financing Activities of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-12 Cr | Negative | |
| Mar2024 | ₹-8.91 Cr | Negative | |
| Mar2023 | ₹-0.46 Cr | Negative | |
| Mar2022 | ₹-18 Cr | Negative | |
| Mar2021 | ₹-6.83 Cr | - | |
Compare Cash Flow from Financing Activities of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,243.7 Cr | -0.3% | 5% | -3.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,209.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,750.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,746.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,851.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹99,268.4 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | -0.3% |
5% |
-3.4% |
| SENSEX | 1.3% |
5.3% |
6.3% |
You may also like the below Video Courses